Načítá se...
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Protein Glycan Coupling Technology (PGCT) uses purposely modified bacterial cells to produce recombinant glycoconjugate vaccines. This vaccine platform holds great potential in this context, namely due to its modular nature, the simplified production process in comparison to traditional chemical con...
Uloženo v:
| Vydáno v: | Microb Cell Fact |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142613/ https://ncbi.nlm.nih.gov/pubmed/34030723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01588-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|